Leiters, a market leading FDA-registered 503B outsourcing provider of high-quality hospital and ophthalmology compounded sterile preparations and pharmacy services, announced today that it has entered into a corporate partnership with EyeConnect International (ECI) in support of their newly created digital ophthalmic clinical networking platform.
EyeConnect International's mission is to create an interactive, online worldwide community of ophthalmologists dedicated to the advancement of the ophthalmology practice and the improvement of patient care.
"We are honored that Leiters recognizes the value of peer to peer education," said David Karcher, Chief Executive Officer for EyeConnect International. "We look forward to working with them as we build our online community and grow into the preferred ophthalmic clinical networking platform."
Leiters, founded in 1926, provides a wide range of ophthalmic medicines and services to ophthalmology providers and is committed to providing healthcare professionals and their patients with the highest quality ready-to-adminster sterile preparations.
"Partnering with ECI demonstrates our long-standing commitment to the ophthalmic community," said Robin Smith Hoke, Chief Executive Officer for Leiters. "We are delighted to announce this relationship and look forward to collaborating with ECI and supporting this new clinical networking platform."
About Leiters
Leiters, founded in 1926, is a trusted FDA-registered 503B outsourcing provider of high-quality hospital and ophthalmology compounded sterile preparations. We are committed to providing healthcare professionals and their patients with high quality outsourced medications. Our team of experts in sterile pharmaceutical manufacturing, repackaging and compounding provide a sophisticated understanding of what it takes to elevate quality and consistency of supply in pharmaceutical outsourcing. We combine a highly experienced team, with robust processes, in a new state-of-the-art outsourcing facility, to ensure delivery of the highest quality medicines. All sterile preparations are produced under the Human Drug Outsourcing Facilities under 503B of the FD&C Act (503B Guidance) and follow Current Good Manufacturing Practices (cGMP). To learn more about how we're Compounding Health™ please visit www.leiters.com.
Contact:
Kari Cashmore, Leiters
(720) 414-7216
Kari.Cashmore@Leiters.com
About Eye Connect International (ECI)
EyeConnect International (ECI) is a global ophthalmic clinic networking platform. It serves as a respected digital peer to peer resource for sharing knowledge and staying up to date, allowing physicians worldwide to network with one another and establish invaluable connections. ECI was established when the EyeConnect platform, which was sponsored by American Society of Cataract and Refractive Surgery (ASCRS), was discontinued. ECI's mission is to create an interactive, online worldwide community of ophthalmologists dedicated to the advancement of the ophthalmology practice and the improvement of patient care. For more information, visit www.eyeconnectinternational.com.
Contact:
David A Karcher, Eye Connect International
(480) 550-2156
Dkarcher765@gmail.com
Leiters Health is a trusted FDA-registered 503B outsourcing provider of high quality ophthalmology and hospital-based services. We are committed to providing healthcare professionals and their patients with high-quality medications. Our team of experts in sterile pharmaceutical manufacturing, repackaging, and pharmacy provides a sophisticated understanding of what it takes to elevate the quality and consistency of supply in outsourcing.
This post is related to:
Manufacturing: 503B Outsourcing Facilities, Compounding Services
